These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1368790)

  • 1. Europe's emerging biopharmaceutical companies.
    Clark CR; Walton F
    Biotechnology (N Y); 1992 Oct; 10(10):1108-10. PubMed ID: 1368790
    [No Abstract]   [Full Text] [Related]  

  • 2. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.
    Mitragotri S; Burke PA; Langer R
    Nat Rev Drug Discov; 2014 Sep; 13(9):655-72. PubMed ID: 25103255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Neurodegenerative Disorders: Synthesis, Drug Delivery Strategies and Biological Evaluation of New Therapeutic Agents.
    Di Stefano A; Reale M
    Cent Nerv Syst Agents Med Chem; 2017; 17(2):89. PubMed ID: 28820058
    [No Abstract]   [Full Text] [Related]  

  • 4. Fostering a new dialogue to improve access to finance for European biopharma SMEs.
    Chantelot E; Suojanen C
    N Biotechnol; 2010 Dec; 27(6):719-23. PubMed ID: 20678597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating investment in biopharmaceutical R&D.
    Carter PH; Berndt ER; DiMasi JA; Trusheim M
    Nat Rev Drug Discov; 2016 Oct; 15(10):673-4. PubMed ID: 27616295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Targets and Innovative Strategies in Cancer Treatment: one year of progress. 13-14 February 2004, Nice, France.
    Swanton C; Johnston S
    IDrugs; 2004 Apr; 7(4):306-11. PubMed ID: 15057631
    [No Abstract]   [Full Text] [Related]  

  • 7. Biopharmaceuticals: recent approvals and likely directions.
    Walsh G
    Trends Biotechnol; 2005 Nov; 23(11):553-8. PubMed ID: 16051388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutical benchmarks--2003.
    Walsh G
    Nat Biotechnol; 2003 Aug; 21(8):865-70. PubMed ID: 12894198
    [No Abstract]   [Full Text] [Related]  

  • 9. Russia through the prism of the world biopharmaceutical market.
    Bairamashvili DI; Rabinovich ML
    Biotechnol J; 2007 Jul; 2(7):801-17. PubMed ID: 17615600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The publishing and patenting strategies of successful university spinoffs in the biopharmaceutical industry.
    Erden Z
    Drug Discov Today; 2017 Jan; 22(1):5-9. PubMed ID: 27634342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceutical innovation and industrial developments in South Korea, Singapore and Taiwan.
    Hsieh CR; Löfgren H
    Aust Health Rev; 2009 May; 33(2):245-57. PubMed ID: 19563313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of and trends in the late-stage biopharmaceutical pipeline.
    Nagle PC; Nicita CA; Gerdes LA; Schmeichel CJ
    Am J Manag Care; 2008 Apr; 14(4):226-9. PubMed ID: 18402515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobile economics and pricing of health care services.
    Huttin CC
    Technol Health Care; 2012; 20(5):459-61. PubMed ID: 23079949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RITA--a small-molecule anticancer drug that targets p53.
    Doggrell SA
    Expert Opin Investig Drugs; 2005 Jun; 14(6):739-42. PubMed ID: 16004600
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methods of obtaining pure enantiomeric compounds].
    Achmatowicz O; Grynkiewicz G
    Acta Pol Pharm; 1993; 50(1):13-74. PubMed ID: 8010144
    [No Abstract]   [Full Text] [Related]  

  • 16. Biopharma in Piedmont, Italy.
    Sakariassen KS
    Nat Rev Drug Discov; 2005 Jun; 4(6):519. PubMed ID: 15959953
    [No Abstract]   [Full Text] [Related]  

  • 17. A perfect storm for innovation.
    Williams RN
    Clin Pharmacol Ther; 2010 Jul; 88(1):23; author reply 23-4. PubMed ID: 20445532
    [No Abstract]   [Full Text] [Related]  

  • 18. Biopharma deal-making in 2016.
    Micklus A; Muntner S
    Nat Rev Drug Discov; 2017 Mar; 16(3):161-162. PubMed ID: 28209988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Microbial biopharmaceuticals and antibody-based drugs--promising for new drug discovery and development].
    Zhen YS
    Yao Xue Xue Bao; 2003 Jul; 38(7):483-4. PubMed ID: 14515788
    [No Abstract]   [Full Text] [Related]  

  • 20. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
    Närhi M; Nordström K
    Eur J Pharm Biopharm; 2005 Apr; 59(3):397-405. PubMed ID: 15760720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.